Semaglutide Use Linked to Erythromelalgia Remission
-
By
-
Kathryn Wighton
-
April 22, 2026
-
4 min
By
Kathryn Wighton
April 22, 2026
Targets type 2 inflammation in a population with limited treatment options
April 24, 2026
Nearly 90% of patients who met algorithmic criteria for postacute sequelae of SARS-CoV-2 infection had at least 1 chronic or potentially chronic condition requiring ongoing clinical management.
June 30, 2026
Randomized study found no statistically significant differences in disease improvement between treatments over 8 weeks.
by Meg Barbor
April 9, 2026